Alain H. Rook

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

H. Clifford Lane, Henry Masur, Lynn C. Edgar et al. · New England Journal of Medicine · 1983 · 1.6K citations

Heterosexual Controls, Immunodeficiencies, Immunology +19

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Sean Whittaker, Marie‐France Demierre, Ellen J. Kim et al. · Journal of Clinical Oncology · 2010 · 650 citations

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Cytotoxic T Cells in Cytomegalovirus Infection

Gerald V. Quinnan, Nigar Kirmani, Alain H. Rook et al. · New England Journal of Medicine · 1982 · 596 citations

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

Alain H. Rook, Henry Masur, H. Clifford Lane et al. · Journal of Clinical Investigation · 1983 · 415 citations · Full text

Immunodeficiencies, Immunology, Ifn Beta +23